Biolife Solutions (BLFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 6,449 | 6,191 | 8,949 | 5,663 | 2,759 |
| Cost of Goods | 2,635 | 3,155 | 5,187 | 3,371 | 1,356 |
| Gross Profit | 3,814 | 3,035 | 3,763 | 2,292 | 1,403 |
| Operating Expenses | 9,466 | 6,326 | 4,235 | 3,605 | 2,968 |
| Operating Income | -5,017 | -3,136 | -285 | -942 | -1,210 |
| Interest Expense | 0 | 177 | 742 | 733 | 671 |
| Other Income | 22 | 12 | -57 | 16 | -76 |
| Pre-tax Income | -4,995 | -3,301 | -1,084 | -1,660 | -1,957 |
| Net Income Continuous | -4,995 | -3,301 | -1,084 | -1,660 | -1,957 |
| Minority Interests | -781 | -83 | N/A | N/A | N/A |
| Net Income | $-4,214 | $-3,218 | $-1,084 | $-1,660 | $-1,957 |
| EPS Basic Total Ops | -0.35 | -0.31 | -0.22 | -0.33 | -0.42 |
| EPS Basic Continuous Ops | -0.41 | -0.32 | -0.22 | -0.33 | -0.39 |
| EPS Diluted Total Ops | -0.35 | -0.31 | -0.22 | -0.33 | -0.42 |
| EPS Diluted Continuous Ops | -0.41 | -0.32 | -0.22 | -0.33 | -0.39 |
| EBITDA(a) | $-4,801 | $-2,865 | $18 | $-694 | $-1,038 |